Fungus and chronic rhinosinusitis: From bench to clinical understanding

Annals of Otology, Rhinology and Laryngology

Volumn 115, Issue 9 II, 2006, Pages 27-34

  Lanza, Donald C ^a,b   Dhong, Hun Jong ^a   Tantilipikorn, Pongsakorn ^a   Tanabodee, Jirayu ^a   Nadel, Douglas M ^a   Kennedy, David W ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b Carillon Outpatient Center   (United States)

Author keywords

Alternaria; Antifungal therapy; Antimycotic therapy; Aspergillus; Dematiaceae; Dematium; Eosinophilia; Fungal rhinosinusitis; Fungal sinusitis

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; CORTICOSTEROID; IMMUNOGLOBULIN E; ITRACONAZOLE; PLACEBO; TERBINAFINE; VORICONAZOLE;

ALTERNARIA; ASPERGILLUS; CANDIDA; CHRONIC RHINITIS; CHRONIC SINUSITIS; COMPUTER ASSISTED TOMOGRAPHY; CONGESTIVE HEART FAILURE; DRUG EFFICACY; EOSINOPHILIA; FUNGUS CULTURE; FUNGUS HYPHAE; GEOGRAPHIC DISTRIBUTION; HUMAN; INFLAMMATION; LIVER FAILURE; MICROSCOPY; MUCOR; MYCOSIS; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; VISUAL DISORDER; ADULT; ASPERGILLOSIS; CASE REPORT; CHRONIC DISEASE; FEMALE; HYPERSENSITIVITY; ISOLATION AND PURIFICATION; MALE; MICROBIOLOGY; MIDDLE AGED; PATHOGENICITY; PATHOPHYSIOLOGY; RHINITIS; SINUSITIS; TREATMENT OUTCOME;

ADULT; ALTERNARIA; ANTIFUNGAL AGENTS; ASPERGILLOSIS; ASPERGILLUS; CHRONIC DISEASE; EOSINOPHILIA; FEMALE; HUMANS; HYPERSENSITIVITY; IMMUNOGLOBULIN E; MALE; MIDDLE AGED; MYCOSES; RHINITIS; RISK FACTORS; SINUSITIS; TREATMENT OUTCOME;

EID: 33748938689     PISSN: 00034894     EISSN: None     Source Type: Journal    
DOI: 10.1177/00034894061150s905     Document Type: Review

References (43)

1. Lethbridge-Cejku MV, Vickerie J. Summary health statistics for US adults: National Health Interview Survey, 2003. Vital Health Stat 2005;10:1-161.
2. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg 2004;131(suppl 6).
3. Plaignaud. Observation sur un fongus du sinus maxillaire. J Chir 1791;1:111.
4. Zarniko C. Aspergillusmykose der Kierferhohle. Deutsche Med 1891;17:1222.
5. Harmer D. Suppuration of the antrum due to Aspergillus fumigatus. J Laryngol Rhinol Otol 1913;28:494.
6. Tilley H. Aspergillosis of the nasal accessory sinuses. J Laryngol Rhinol Otol 1915;30:145.
7. Miloshev B, Davidson CM, Gentles JC, Sandison AT. Aspergilloma of paranasal sinuses and orbit in Northern Sudanese. Lancet 1966;1:746-7.
8. Katzenstein AL, Sale SR, Greenberger PA. Allergic Aspergillus sinusitis: a newly recognized form of sinusitis. J Allergy Clin Immunol 1983;72:89-93.
9. Waxman JE, Spector JG, Sale SR, Katzenstein AL. Allergic Aspergillus sinusitis: concepts in diagnosis and treatment of a new clinical entity. Laryngoscope 1987;97:261-6.
10. Stammberger H, Jakse R, Beaufort F. Aspergillosis of the paranasal sinuses. X-ray diagnosis, histopathology, and clinical aspects. Ann Otol Rhinol Laryngol 1984;93:251-6.
11. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc 1999;74:877-84.
12. Perez-Jaffe LA, Lanza DC, Loevner LA, Kennedy DW, Montone KT. In situ hybridization for Aspergillus and Penicillium in allergic fungal sinusitis: a rapid means of speciating fungal pathogens in tissues. Laryngoscope 1997;107:233-40.
13. Bent JP III, Kuhn FA. Allergic fungal sinusitis/polyposis. Allergy Asthma Proc 1996;17:259-68.
14. Ferguson BJ. Definitions of fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33:227-35.
15. Ferguson BJ. Eosinophilic mucin rhinosinusitis: a distinct clinicopathological entity. Laryngoscope 2000;110:799-813.
16. Washburn RG, Kennedy DW, Begley MG, Henderson DK, Bennett JE. Chronic fungal sinusitis in apparently normal hosts. Medicine (Baltimore) 1988;67:231-47.
17. Stringer SP, Ryan MW. Chronic invasive fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33:375-87.
18. Mirza N, Lanza DC. Diagnosis and management of rhinosinusitis before scheduled immunosuppression: a schematic-approach to the prevention of acute fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33:313-21.
19. Ferguson BJ, Barnes L, Bernstein JM, et al. Geographic variation in allergic fungal rhinosinusitis. Otolaryngol Clin North Am 2000;33:441-9.
20. Small P, Barrett D, Frenkiel S, Rochon L, Cohen C, Black M. Local specific IgE production in nasal polyps associated with negative skin tests and serum RAST. Ann Allergy 1985;55:736-9.
21. Cody DT II, Neel HB III, Ferreiro JA, Roberts GD. Allergic fungal sinusitis: the Mayo Clinic experience. Laryngoscope 1994;104:1074-9.
22. Mabry RL, Manning SC, Mabry CS. Immunotherapy in the treatment of allergic fungal sinusitis. Otolaryngol Head Neck Surg 1997;116:31-5.
23. Bassichis BA, Marple BF, Mabry RL, Newcomer MT, Schwade ND. Use of immunotherapy in previously treated patients with allergic fungal sinusitis. Otolaryngol Head Neck Surg 2001;125:487-90.
24. Collins M, Nair S, Smith W, Kette F, Gillis D, Wormald PJ. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope 2004;114:1242-6.
25. Pant H, Kette FE, Smith WB, Wormald PJ, Macardle PJ. Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope 2005;115:601-6.
26. Terada N, Konno A, Shirotori K, et al. Mechanism of eosinophil infiltration in the patient with subcutaneous angioblastic lymphoid hyperplasia with eosinophilia (Kimura's disease). Mechanism of eosinophil chemotaxis mediated by Candida antigen and IL-5. Int Arch Allergy Immunol 1994;104(suppl 1):18-20.
27. Wei JL, Kita H, Sherris DA, Kern EB, Weaver A, Ponikau JU. The chemotactic behavior of eosinophils in patients with chronic rhinosinusitis. Laryngoscope 2003;113:303-6.
28. Bhattacharyya N, Fried MP. Peripheral eosinophilia in the diagnosis of chronic rhinosinusitis. Am J Otolaryngol 2001;22:116-20.
29. Bhattacharyya N, Vyas DK, Fechner FP, Gliklich RE, Metson R. Tissue eosinophilia in chronic sinusitis: quantification techniques. Arch Otolaryngol Head Neck Surg 2001;127:1102-5.
30. Shin SH, Ponikau JU, Sherris DA, et al. Chronic rhinosinusitis: an enhanced immune response to ubiquitous airborne fungi. J Allergy Clin Immunol 2004;114:1369-75.
31. Gosepath J, Brieger J, Vlachtsis K, Mann WJ. Fungal DNA is present in tissue specimens of patients with chronic rhinosinusitis. Am J Rhinol 2004;18:9-13.
32. Visconti A, Sibilia A. Alternaria toxins. In: Miller JT, Trenholm HL, eds. Mycotoxins in grain. Compounds other than aflatoxin. St Paul, Minn: Eagan Press, 1994:315-36.
33. Zhang N, Gevaert P, van Zele T, et al. An update on the impact of Staphylococcus aureus enterotoxins in chronic sinusitis with nasal polyposis. Rhinology 2005;43:162-8.
34. Clement S, Vaudaux P, Francois P, et al. Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 2005;192:1023-8.
35. Hwang PH, Montone KT, Gannon FH, Senior BA, Lanza DC, Kennedy DW. Applications of in situ hybridization techniques in the diagnosis of chronic sinusitis. Am J Rhinol 1999;13:335-8.
36. Rains BM III, Mineck CW. Treatment of allergic fungal sinusitis with high-dose itraconazole. Am J Rhinol 2003;17:1-8.
37. Ricchetti A, Landis BN, Maffioli A, Giger R, Zeng C, Lacroix JS. Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis. J Laryngol Otol 2002;116:261-3.
38. Ponikau JU, Sherris DA, Weaver A, Kita H. Treatment of chronic rhinosinusitis with intranasal amphotericin B: a randomized, placebo-controlled, double-blind pilot trial. J Allergy Clin Immunol 2005;115:125-31.
39. Jornot L, Rochat T, Lacroix JS. Nasal polyps and middle turbinates epithelial cells sensitivity to amphotericin B. Rhinology 2003;41:201-5.
40. [Erratum in Rhinology 2004;42:110.]
41. Kennedy DW, Kuhn FA, Hamilos DL, et al. Treatment of chronic rhinosinusitis with high-dose oral terbinafine: a double blind, placebo-controlled study. Laryngoscope 2005;115:1793-9.
42. Sporanox Prescribing Information. Janssen Pharmaceutica Products, LP. Available at: www.sporanox.com/html/spx/pd_consumer.xml?article= prescribing_consumer.jspf. Accessed March 3, 2006.
43. VFEND Prescribing Information. Pfizer Inc. Available at: www.pfizer.com/pfizer/download/uspi_vfend.pdf. Accessed March 3, 2006.